3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
5
Phase 2
2
Phase NA
1
Phase EARLY_PHASE1
1
Phase 3
1
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
141
Other hematologic neoplasm
109
Plasma cell
62
CNS
37
Sarcoma
27
Gynecologic
27
Thoracic
21
Gastrointestinal
19
Myeloid
18
Dermatologic
12
Head & Neck
11
Genitourinary
11
Breast
11
Endocrine
2
Classical hematology
2
Other solid neoplasm
1
NET
1
Conditions
Advanced Solid Tumor
102
Advanced Solid Tumors
91
Solid Tumor
67
Mesothelioma
42
Mesothelioma, Malignant
41
Solid Tumors
37
Carcinoma, Non-Small-Cell Lung
25
Solid Tumor, Adult
22
Stomach Neoplasms
15
Ovarian Neoplasms
15
Esophageal Neoplasms
15
Melanoma
13
Colorectal Neoplasms
13
Carcinoma, Renal Cell
13
Endometrial Neoplasms
11
Unspecified Adult Solid Tumor, Protocol Specific
10
Pancreatic Neoplasms
10
Neoplasms
10
Neoplasm Metastasis
10
Advanced Malignant Solid Tumor
10
Uterine Cervical Neoplasms
9
Malignant Solid Tumor
9
Lung Neoplasms
9
Breast Neoplasms
9
Triple Negative Breast Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
8
Sarcoma
8
Advanced or Metastatic Solid Tumors
8
Carcinoma, Hepatocellular
7
Small Cell Lung Carcinoma
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Recurrence
×
Other solid neoplasm
×
Clear all
NCT06051695
2026-05-26
EVEREST-2
A2 Biotherapeutics Inc.
Phase 1/2
Recruiting
474 enrolled